BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6975788)

  • 1. Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer.
    Füst G; Fekete B; Angyal I; Jakab A; Pál A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M
    J Immunol Methods; 1981; 46(3):259-76. PubMed ID: 6975788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of circulating immune complex levels in advanced lung cancer. A discrimination analysis.
    Fekete B; Füst G; Pál A; Angyal I; Jakab A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M
    Oncology; 1983; 40(2):106-10. PubMed ID: 6828286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of cultured human myeloid cells (K562) for detection of immune complexes in human sera.
    Gupta RK; Huth JF; Golub SH
    Immunol Commun; 1982; 11(5):401-19. PubMed ID: 6984006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA; Mooney NA; Nineham LJ; Hay FC
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurement of circulating immune complexes in healthy subjects.
    Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
    Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol.
    Digeon M; Laver M; Riza J; Bach JF
    J Immunol Methods; 1977; 16(2):165-83. PubMed ID: 881555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantibodies, autoantibodies, and immune complexes in patients with lung cancer.
    Górny MK; Lawniczak M; Jenek R; Słowik-Gabryelska A; Kaczmarek E; Zeromski J
    Lung; 1988; 166(2):97-105. PubMed ID: 2835557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study.
    Füst G; Kavai M; Szegedi G; Meretey K; Falus A; Lenkey A; Misz M
    J Immunol Methods; 1980; 38(3-4):281-9. PubMed ID: 7440977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration and differentiation of circulating immune complexes in chronic inflammatory rheumatic diseases using a semiautomated PEG-precipitation laser nephelometer test].
    Geissler N; Kemper A; Krapf E; Renger D; Schedel I; Deicher H
    Z Rheumatol; 1985; 44(2):57-63. PubMed ID: 4050141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methods of determining circulating immune complexes].
    Baleva M
    Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.